InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: A deleted message

Friday, 09/30/2016 10:19:01 PM

Friday, September 30, 2016 10:19:01 PM

Post# of 345786
Guess you don't know about the tail

The tail that is alive and well

PS Targeting with some key biomarkers can predict who will live long and now the FDA will have statistically significant data to make a decision : )

A decision that will burn deep into the souls of some Big Pharma ... but the time has come

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News